Global Transdermal Scopolamine Market Professional Survey Report 2018

February 2018 | 108 pages | ID: G47C10339C4QEN
QYResearch

Abstracts

This report studies Transdermal Scopolamine in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Baxter International Inc.
• GlaxoSmithKline plc
• Novartis AG
• Perrigo Company plc.
• Caleb Pharmaceuticals, Inc.
• Myungmoon Pharma Co. LTD.
• ...

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Tablet Type
• Syrups Type
• Injections Type
• Patch Type
• Gel Type

By Application, the market can be split into

• Hospital
• Clinic
• Ambulance Center
• Others

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Transdermal Scopolamine Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF TRANSDERMAL SCOPOLAMINE

1.1 Definition and Specifications of Transdermal Scopolamine
  1.1.1 Definition of Transdermal Scopolamine
  1.1.2 Specifications of Transdermal Scopolamine
1.2 Classification of Transdermal Scopolamine
  1.2.1 Tablet Type
  1.2.2 Syrups Type
  1.2.3 Injections Type
  1.2.4 Patch Type
  1.2.5 Gel Type
1.3 Applications of Transdermal Scopolamine
  1.3.1 Hospital
  1.3.2 Clinic
  1.3.3 Ambulance Center
  1.3.4 Others
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF TRANSDERMAL SCOPOLAMINE

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Transdermal Scopolamine
2.3 Manufacturing Process Analysis of Transdermal Scopolamine
2.4 Industry Chain Structure of Transdermal Scopolamine

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF TRANSDERMAL SCOPOLAMINE

3.1 Capacity and Commercial Production Date of Global Transdermal Scopolamine Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Transdermal Scopolamine Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Transdermal Scopolamine Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Transdermal Scopolamine Major Manufacturers in 2016

4 GLOBAL TRANSDERMAL SCOPOLAMINE OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Transdermal Scopolamine Capacity and Growth Rate Analysis
  4.2.2 2016 Transdermal Scopolamine Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Transdermal Scopolamine Sales and Growth Rate Analysis
  4.3.2 2016 Transdermal Scopolamine Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Transdermal Scopolamine Sales Price
  4.4.2 2016 Transdermal Scopolamine Sales Price Analysis (Company Segment)

5 TRANSDERMAL SCOPOLAMINE REGIONAL MARKET ANALYSIS

5.1 North America Transdermal Scopolamine Market Analysis
  5.1.1 North America Transdermal Scopolamine Market Overview
  5.1.2 North America 2012-2017E Transdermal Scopolamine Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Transdermal Scopolamine Sales Price Analysis
  5.1.4 North America 2016 Transdermal Scopolamine Market Share Analysis
5.2 China Transdermal Scopolamine Market Analysis
  5.2.1 China Transdermal Scopolamine Market Overview
  5.2.2 China 2012-2017E Transdermal Scopolamine Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Transdermal Scopolamine Sales Price Analysis
  5.2.4 China 2016 Transdermal Scopolamine Market Share Analysis
5.3 Europe Transdermal Scopolamine Market Analysis
  5.3.1 Europe Transdermal Scopolamine Market Overview
  5.3.2 Europe 2012-2017E Transdermal Scopolamine Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Transdermal Scopolamine Sales Price Analysis
  5.3.4 Europe 2016 Transdermal Scopolamine Market Share Analysis
5.4 Southeast Asia Transdermal Scopolamine Market Analysis
  5.4.1 Southeast Asia Transdermal Scopolamine Market Overview
  5.4.2 Southeast Asia 2012-2017E Transdermal Scopolamine Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Transdermal Scopolamine Sales Price Analysis
  5.4.4 Southeast Asia 2016 Transdermal Scopolamine Market Share Analysis
5.5 Japan Transdermal Scopolamine Market Analysis
  5.5.1 Japan Transdermal Scopolamine Market Overview
  5.5.2 Japan 2012-2017E Transdermal Scopolamine Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Transdermal Scopolamine Sales Price Analysis
  5.5.4 Japan 2016 Transdermal Scopolamine Market Share Analysis
5.6 India Transdermal Scopolamine Market Analysis
  5.6.1 India Transdermal Scopolamine Market Overview
  5.6.2 India 2012-2017E Transdermal Scopolamine Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Transdermal Scopolamine Sales Price Analysis
  5.6.4 India 2016 Transdermal Scopolamine Market Share Analysis

6 GLOBAL 2012-2017E TRANSDERMAL SCOPOLAMINE SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Transdermal Scopolamine Sales by Type
6.2 Different Types of Transdermal Scopolamine Product Interview Price Analysis
6.3 Different Types of Transdermal Scopolamine Product Driving Factors Analysis
  6.3.1 Tablet Type of Transdermal Scopolamine Growth Driving Factor Analysis
  6.3.2 Syrups Type of Transdermal Scopolamine Growth Driving Factor Analysis
  6.3.3 Injections Type of Transdermal Scopolamine Growth Driving Factor Analysis
  6.3.4 Patch Type of Transdermal Scopolamine Growth Driving Factor Analysis
  6.3.5 Gel Type of Transdermal Scopolamine Growth Driving Factor Analysis

7 GLOBAL 2012-2017E TRANSDERMAL SCOPOLAMINE SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Transdermal Scopolamine Consumption by Application
7.2 Different Application of Transdermal Scopolamine Product Interview Price Analysis
7.3 Different Application of Transdermal Scopolamine Product Driving Factors Analysis
  7.3.1 Hospital of Transdermal Scopolamine Growth Driving Factor Analysis
  7.3.2 Clinic of Transdermal Scopolamine Growth Driving Factor Analysis
  7.3.3 Ambulance Center of Transdermal Scopolamine Growth Driving Factor Analysis
  7.3.4 Others of Transdermal Scopolamine Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF TRANSDERMAL SCOPOLAMINE

8.1 Baxter International Inc.
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Baxter International Inc. 2016 Transdermal Scopolamine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Baxter International Inc. 2016 Transdermal Scopolamine Business Region Distribution Analysis
8.2 GlaxoSmithKline plc
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 GlaxoSmithKline plc 2016 Transdermal Scopolamine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 GlaxoSmithKline plc 2016 Transdermal Scopolamine Business Region Distribution Analysis
8.3 Novartis AG
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Novartis AG 2016 Transdermal Scopolamine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Novartis AG 2016 Transdermal Scopolamine Business Region Distribution Analysis
8.4 Perrigo Company plc.
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Perrigo Company plc. 2016 Transdermal Scopolamine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Perrigo Company plc. 2016 Transdermal Scopolamine Business Region Distribution Analysis
8.5 Caleb Pharmaceuticals, Inc.
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Caleb Pharmaceuticals, Inc. 2016 Transdermal Scopolamine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Caleb Pharmaceuticals, Inc. 2016 Transdermal Scopolamine Business Region Distribution Analysis
8.6 Myungmoon Pharma Co. LTD.
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Myungmoon Pharma Co. LTD. 2016 Transdermal Scopolamine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Myungmoon Pharma Co. LTD. 2016 Transdermal Scopolamine Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF TRANSDERMAL SCOPOLAMINE MARKET

9.1 Global Transdermal Scopolamine Market Trend Analysis
  9.1.1 Global 2017-2022 Transdermal Scopolamine Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Transdermal Scopolamine Sales Price Forecast
9.2 Transdermal Scopolamine Regional Market Trend
  9.2.1 North America 2017-2022 Transdermal Scopolamine Consumption Forecast
  9.2.2 China 2017-2022 Transdermal Scopolamine Consumption Forecast
  9.2.3 Europe 2017-2022 Transdermal Scopolamine Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Transdermal Scopolamine Consumption Forecast
  9.2.5 Japan 2017-2022 Transdermal Scopolamine Consumption Forecast
  9.2.6 India 2017-2022 Transdermal Scopolamine Consumption Forecast
9.3 Transdermal Scopolamine Market Trend (Product Type)
9.4 Transdermal Scopolamine Market Trend (Application)

10 TRANSDERMAL SCOPOLAMINE MARKETING TYPE ANALYSIS

10.1 Transdermal Scopolamine Regional Marketing Type Analysis
10.2 Transdermal Scopolamine International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Transdermal Scopolamine by Region
10.4 Transdermal Scopolamine Supply Chain Analysis

11 CONSUMERS ANALYSIS OF TRANSDERMAL SCOPOLAMINE

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL TRANSDERMAL SCOPOLAMINE MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Transdermal Scopolamine
Table Product Specifications of Transdermal Scopolamine
Table Classification of Transdermal Scopolamine
Figure Global Production Market Share of Transdermal Scopolamine by Type in 2016
Figure Tablet Type Picture
Table Major Manufacturers of Tablet Type
Figure Syrups Type Picture
Table Major Manufacturers of Syrups Type
Figure Injections Type Picture
Table Major Manufacturers of Injections Type
Figure Patch Type Picture
Table Major Manufacturers of Patch Type
Figure Gel Type Picture
Table Major Manufacturers of Gel Type
Table Applications of Transdermal Scopolamine
Figure Global Consumption Volume Market Share of Transdermal Scopolamine by Application in 2016
Figure Hospital Examples
Table Major Consumers in Hospital
Figure Clinic Examples
Table Major Consumers in Clinic
Figure Ambulance Center Examples
Table Major Consumers in Ambulance Center
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Transdermal Scopolamine by Regions
Figure North America Transdermal Scopolamine Market Size (Million USD) (2012-2022)
Figure China Transdermal Scopolamine Market Size (Million USD) (2012-2022)
Figure Europe Transdermal Scopolamine Market Size (Million USD) (2012-2022)
Figure Southeast Asia Transdermal Scopolamine Market Size (Million USD) (2012-2022)
Figure Japan Transdermal Scopolamine Market Size (Million USD) (2012-2022)
Figure India Transdermal Scopolamine Market Size (Million USD) (2012-2022)
Table Transdermal Scopolamine Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Transdermal Scopolamine in 2016
Figure Manufacturing Process Analysis of Transdermal Scopolamine
Figure Industry Chain Structure of Transdermal Scopolamine
Table Capacity and Commercial Production Date of Global Transdermal Scopolamine Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Transdermal Scopolamine Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Transdermal Scopolamine Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Transdermal Scopolamine Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Transdermal Scopolamine 2012-2017
Figure Global 2012-2017E Transdermal Scopolamine Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Transdermal Scopolamine Market Size (Value) and Growth Rate
Table 2012-2017E Global Transdermal Scopolamine Capacity and Growth Rate
Table 2016 Global Transdermal Scopolamine Capacity (Units) List (Company Segment)
Table 2012-2017E Global Transdermal Scopolamine Sales (Units) and Growth Rate
Table 2016 Global Transdermal Scopolamine Sales (Units) List (Company Segment)
Table 2012-2017E Global Transdermal Scopolamine Sales Price (K USD/Unit)
Table 2016 Global Transdermal Scopolamine Sales Price (K USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (Units) of Transdermal Scopolamine 2012-2017E
Figure North America 2012-2017E Transdermal Scopolamine Sales Price (K USD/Unit)
Figure North America 2016 Transdermal Scopolamine Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (Units) of Transdermal Scopolamine 2012-2017E
Figure China 2012-2017E Transdermal Scopolamine Sales Price (K USD/Unit)
Figure China 2016 Transdermal Scopolamine Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (Units) of Transdermal Scopolamine 2012-2017E
Figure Europe 2012-2017E Transdermal Scopolamine Sales Price (K USD/Unit)
Figure Europe 2016 Transdermal Scopolamine Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (Units) of Transdermal Scopolamine 2012-2017E
Figure Southeast Asia 2012-2017E Transdermal Scopolamine Sales Price (K USD/Unit)
Figure Southeast Asia 2016 Transdermal Scopolamine Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (Units) of Transdermal Scopolamine 2012-2017E
Figure Japan 2012-2017E Transdermal Scopolamine Sales Price (K USD/Unit)
Figure Japan 2016 Transdermal Scopolamine Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (Units) of Transdermal Scopolamine 2012-2017E
Figure India 2012-2017E Transdermal Scopolamine Sales Price (K USD/Unit)
Figure India 2016 Transdermal Scopolamine Sales Market Share
Table Global 2012-2017E Transdermal Scopolamine Sales (Units) by Type
Table Different Types Transdermal Scopolamine Product Interview Price
Table Global 2012-2017E Transdermal Scopolamine Sales (Units) by Application
Table Different Application Transdermal Scopolamine Product Interview Price
Table Baxter International Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Baxter International Inc. Transdermal Scopolamine Revenue (Million USD), Sales (Units), Ex-factory Price (K USD/Unit)
Figure 2016 Baxter International Inc. Transdermal Scopolamine Business Region Distribution
Table GlaxoSmithKline plc Information List
Table Product A Overview
Table Product B Overview
Table 2016 GlaxoSmithKline plc Transdermal Scopolamine Revenue (Million USD), Sales (Units), Ex-factory Price (K USD/Unit)
Figure 2016 GlaxoSmithKline plc Transdermal Scopolamine Business Region Distribution
Table Novartis AG Information List
Table Product A Overview
Table Product B Overview
Table 2015 Novartis AG Transdermal Scopolamine Revenue (Million USD), Sales (Units), Ex-factory Price (K USD/Unit)
Figure 2016 Novartis AG Transdermal Scopolamine Business Region Distribution
Table Perrigo Company plc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Perrigo Company plc. Transdermal Scopolamine Revenue (Million USD), Sales (Units), Ex-factory Price (K USD/Unit)
Figure 2016 Perrigo Company plc. Transdermal Scopolamine Business Region Distribution
Table Caleb Pharmaceuticals, Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Caleb Pharmaceuticals, Inc. Transdermal Scopolamine Revenue (Million USD), Sales (Units), Ex-factory Price (K USD/Unit)
Figure 2016 Caleb Pharmaceuticals, Inc. Transdermal Scopolamine Business Region Distribution
Table Myungmoon Pharma Co. LTD. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Myungmoon Pharma Co. LTD. Transdermal Scopolamine Revenue (Million USD), Sales (Units), Ex-factory Price (K USD/Unit)
Figure 2016 Myungmoon Pharma Co. LTD. Transdermal Scopolamine Business Region Distribution
Figure Global 2017-2022 Transdermal Scopolamine Market Size (Units) and Growth Rate Forecast
Figure Global 2017-2022 Transdermal Scopolamine Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Transdermal Scopolamine Sales Price (K USD/Unit) Forecast
Figure North America 2017-2022 Transdermal Scopolamine Consumption Volume (Units) and Growth Rate Forecast
Figure China 2017-2022 Transdermal Scopolamine Consumption Volume (Units) and Growth Rate Forecast
Figure Europe 2017-2022 Transdermal Scopolamine Consumption Volume (Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Transdermal Scopolamine Consumption Volume (Units) and Growth Rate Forecast
Figure Japan 2017-2022 Transdermal Scopolamine Consumption Volume (Units) and Growth Rate Forecast
Figure India 2017-2022 Transdermal Scopolamine Consumption Volume (Units) and Growth Rate Forecast
Table Global Sales Volume (Units) of Transdermal Scopolamine by Type 2017-2022
Table Global Consumption Volume (Units) of Transdermal Scopolamine by Application 2017-2022
Table Traders or Distributors with Contact Information of Transdermal Scopolamine by Region